February 27, 2019
Too much, too late? Patterns of drug prescribing for older adults near the end of life
Lucas Morin - Aging Research Center, Karolinska Institutet, Stockholm, Sweden
Pharmacie Didactique, from 12 am to 1 pm
Related references:
- Morin L, Laroche ML, Vetrano DL, Fastbom J, Johnell K. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus. Eur J Clin Pharmacol. 2018 Jun 23 (ePub)
- Kempf E, Tournigand C, Rochigneux P, Aubry R, Morin L. Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study. Eur J Cancer. 2017 Jul;79:31-40
- Morin L, Vetrano DL, Rizzuto D, Calderón-Larrañaga A, Fastbom J, Johnell K. Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study. Am J Med. 2017 Aug;130(8):927-936.e9
- Morin L, Vetrano DL, Grande G, Fratiglioni L, Fastbom J, Johnell K. Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia. J Am Med Dir Assoc. 2017 Jun 1;18(6):551.e1-551.e7
Info : Anne Spinewine